Bioscience Health Innovations's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Bioscience Health Innovations's ROA in the second quarter of 2026?
Bioscience Health Innovations, Inc. recorded a cumulative net loss of $-1 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -31.94%.

However, within the Technology sector BioScience Health Innovations, Inc. achieved the highest return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 132 to 2628.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	3.83 %	67.06 %	95.4 %	397.26 %	863.61 %
Y / Y Net Income Change	-	-	-	-	516.85 %
Net Income (TTM) in million	-1	0	1	1	1
Return On Assets (TTM)	-31.94 %	-0.72 %	35.54 %	55.42 %	80.2 %
BHIC's Total Ranking	# 2628	# 132	# 67	# 55	# 65
Total Assets (TTM) in million	2	2	2	2	2
Seq. Total Assets Change	-8.33 %	36.49 %	-17.41 %	0.48 %	47.5 %
Seq. Net Income Change	-	-	-	-	7.24 %

BHIC's 5 Years Annual ROA >> Back to BHIC Management Effectiveness >> Compare BHIC ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	# 0

Return On Assets Statistics
High	Average	Low
80.19 %	-319.63 %	-1409.41 %
(Jun 30 2025)		(Mar 31 2023)

Financial Statements
Bioscience Health Innovations's Assets	$ 2 million	BHIC's Balance sheet
Bioscience Health Innovations's Income	$ 0 million	Quarterly BHIC's Income Statement
BHIC's Income by Division		See BHIC's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2022) FY 2023	(Aug 31 2022) FY 2022	(Aug 31 2021) FY 2021
Y / Y Total Assets Change	95.4 %	2656.15 %	94.48 %	158.73 %	-69.42 %
Total Assets in million	2	1	0	0	0
Y / Y Net Income Change	638.05 %	-	-	-	-
Net Income in million	1	0	0	0	0
Annual Return On Assets	37.61 %	9.96 %	-537.54 %	-510.43 %	-406.35 %

BHIC's 5 Years Annual ROA >> Back to BHIC Management Effectiveness >> Compare BHIC ROA to its Competitors

Comment on BHIC's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 37.61 % compared to prior year, due to annual net income growth of 638.05 % to $0.64 million, while value of Bioscience Health Innovations's overall assets grew just by 95.4 % to $1.71 million, compared to $1.71 a year before.

More Return On Assets Ratios
BHIC's' Return on Assets at Yahoo Finance
Cloud Computing & Data Analytics Industry Return On Assets Trends and Statistics
Technology Sector Roa Statistics
Roa Trends for overall market
BHIC's Roa Ratio versus Cloud Computing & Data Analytics Industry, Technology Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BHIC's Competitors
Subscribers only: Roa for Bioscience Health Innovations's Suppliers
Subscribers only: Return On Assets for BHIC's Customers

You may also want to know
BHIC's Roi	BHIC's Inventory Turnover Ratio	BHIC's Growth Rates	BHIC's Dividend Comparisons
	BHIC's Profitability Ratios	BHIC's Asset Turnover Ratio	BHIC's Dividend Growth
BHIC's Roe	BHIC's Valuation Ratios	BHIC's Financial Strength Ratios	BHIC's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Technology Sector

ROA

Date modified: 2026-08-14T16:50:52+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.